Actively Recruiting
Tegoprazan-containing Sequential for H. Pylori
Led by Seoul National University Bundang Hospital · Updated on 2026-04-28
400
Participants Needed
1
Research Sites
305 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
As H. pylori eradication, the investigators prepared a randomized controlled clinical trial whether tegoprazan-containing 10-day sequential treatment was effective compared to conventional PPI-containing 10-day sequential eradication therapy
CONDITIONS
Official Title
Tegoprazan-containing Sequential for H. Pylori
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Confirmed Helicobacter pylori infection by positive urea breath test, rapid urease test, or pathologic examination (Warthin-Giemsa staining)
You will not qualify if you...
- Congestive heart failure classified as NYHA III or IV
- End-stage renal disease
- Alcohol abuse
- Drug abuse
- Pregnant or nursing women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707
Actively Recruiting
Research Team
J
Jungwon Lee, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here